Which of the following tests is commonly used to evaluate menopause status?

FSH levels, or follicle-stimulating hormone levels, are commonly used to evaluate menopausal status because they reflect changes in the body’s hormonal environment as a woman transitions toward menopause. During perimenopause and menopause, ovarian function declines, leading to decreased levels of estrogen and an increase in FSH. This correlation makes FSH a reliable marker for assessing whether a woman is in menopause, as elevated FSH levels (typically above 30 mIU/mL) indicate reduced ovarian function.

In contrast, insulin sensitivity tests, thyroid function tests, and complete blood counts are not specific indicators of menopause. An insulin sensitivity test assesses how well the body responds to insulin and is more relevant for metabolic health conditions like diabetes. Thyroid function tests evaluate thyroid hormone production and can help diagnose conditions like hyperthyroidism or hypothyroidism, which may present with symptoms overlapping those of menopause but are not directly related to menopausal status. A complete blood count is utilized to evaluate overall health and detect a variety of disorders such as anemia or infection, but it does not provide information about hormonal changes associated with menopause.